Rx only · Injection · Intra-Arterial

Ioversol

Brands: Optiray 300 · Optiray 320 · Optiray 350 · Ioversol

1 ACTIVE SUPPLIER — US

openFDA · updated weekly

US3 NDCs
1 active makers

UKComing
soon

CAComing
soon

AUComing
soon

EUComing
soon

ATC—

RxCUI (US)849882

US makers1 labelers

Packages55

DEA / ScheduleNone

Medicaid dispensing volume

No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

Labeler	Type	Packages	Status
Liebel-Flarsheim Company LLC	unknown	55	SUPPLYING

Shortages, recalls, and registration changes attached to this drug concept.

Sep 13, 2019
RECALLRecall (Class II): Optiray 320 (ioversol) Injection 68%, 320 mg/mL Organically Bound Iodine, packaged in 1 - 100 mL Ultraject Prefilled Sy…
Labeling: Not Elsewhere Classified: RFID formatting error which reads product in Ultraject syringe as expired and will not allow injection of product by the Optivantage injector. — Recalling firm: GUERBET LLC — Nationwide in the USA